Targeting pro-resolving GPCRs to treat cardiopulmonary disease

Date

Time

  @ -

About the talk: Dr Qin’s team focuses on targeting a group of G-protein coupled-receptors involved in the resolution of inflammation. Importantly, they provided the first evidence that selectively engaging beneficial pathways at this receptor have significant therapeutic potential. Helena has publications including in prestigious Nature Communications, Circulation, British Journal of Pharmacology, Journal of Medicinal Chemistry, Pharmacology & Therapeutics. She has attracted research funding from NHMRC, National Heart Foundation, National Drug Discovery Centre, Diabetes Australia, CASS Foundation etc. Her team is driving the resolution pharmacology R&D program towards commercialisation, with experience spanning molecular & integrative pharmacology, rational drug design and commercialisation.

Speaker

  • Dr Cheng Xue Helena Qin

    Dr Qin is an emerging translational pharmacologist with a research vision to develop “pro-resolving medicines” for cardiopulmonary disease. She completed her PhD at the Department of Pharmacology & Therapeutics and School of Chemistry (Uni Melb), before taking up a post-doctoral position at Baker Institute (2011). She was promoted to Group Leader and awarded …

    Dr Qin is an emerging translational pharmacologist with a research vision to develop “pro-resolving medicines” for cardiopulmonary disease. She completed her PhD at the Department of Pharmacology & Therapeutics and School of Chemistry (Uni Melb), before taking up a post-doctoral position at Baker Institute (2011). She was promoted to Group Leader and awarded Baker-Fellowship (2017), and recruited to Monash Institute of Pharmaceutical Sciences to establish her independent laboratory (2021). Her achievements have also been recognized by highly competitive awards including Monash Future Research-Leader Award (2020), AHA Paul Dudley White International Scholar Award (2020), ISHR Best ECS Award (2017), CSANZ Ralph Reader Prize (2016), ASCEPT/BJP Outstanding Young-Investigator Award (2015).